Welcome to our dedicated page for Genpact SEC filings (Ticker: G), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Genpact's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Genpact's regulatory disclosures and financial reporting.
Genpact Limited reported that Senior Vice President Riju Vashisht received an equity award of 21,371 common-share RSUs on January 30, 2026 at a price of $0 per share, reflecting a stock-based compensation grant rather than an open-market purchase.
Following this award, Vashisht beneficially owns 116,892 Genpact common shares in total. The RSUs vest in three equal installments, with one-third vesting on January 10, 2027, one-third on January 10, 2028, and the final third on January 10, 2029, subject to continued service.
Genpact Limited’s Chief Financial Officer Michael Hal Weiner received an equity award of 35,396 common shares on January 30, 2026. The award was granted at a price of $0 per share in the form of restricted share units under the Genpact Limited 2017 Omnibus Incentive Compensation Plan.
Each RSU converts into one common share upon vesting. One-third of the shares are scheduled to vest on each of January 10, 2027, January 10, 2028 and January 10, 2029, conditioned on his continued service. Following this grant, he beneficially owned 171,471 common shares in total.
Genpact Ltd President and CEO Balkrishan Kalra reported a tax‑withholding transaction involving 29,691 common shares. On 01/10/2026, 29,691 Genpact common shares were withheld at a price of $48.24 per share to pay taxes due upon the vesting of restricted share units granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan, in a transaction coded "F" and exempt under Rule 16b-3.
After this withholding, Kalra directly holds 390,685 common shares of Genpact. This event reflects shares being retained by the company for tax purposes rather than an open-market sale.
Genpact Ltd senior vice president Sameer Dewan reported two transactions in Genpact common shares. On January 10, 2026, 9,780 shares were withheld at $48.24 per share to cover taxes upon the vesting of restricted share units granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. After this withholding, Dewan beneficially owned 52,837 shares directly.
On January 13, 2026, Dewan sold 15,088 common shares at a weighted average price of $46.65 per share, with actual sale prices ranging from $46.40 to $47.05. These sales were made under a Rule 10b5-1 trading plan adopted on September 15, 2025. Following the sale, Dewan directly held 37,749 Genpact common shares.
Genpact Limited senior vice president Anil Nanduru reported a tax-related share withholding tied to equity compensation. On January 10, 2026, 11,871 common shares of Genpact Limited were withheld at a price of $48.24 per share. The filing explains these shares were withheld to pay taxes upon the vesting of restricted share units granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan and are exempt under Rule 16b-3.
After this transaction, Nanduru beneficially owned 77,975 common shares, held directly. The activity reflects routine tax withholding on vested stock awards rather than an open-market purchase or sale.
Genpact Limited senior vice president Riju Vashisht reported two transactions in the company’s common shares. On January 10, 2026, 10,733 shares were withheld to cover taxes upon vesting of restricted share units under the Genpact Limited 2017 Omnibus Incentive Compensation Plan at a price of $48.24 per share. This was a tax-related withholding rather than an open-market sale.
On January 13, 2026, Vashisht sold 16,016 common shares at a weighted average price of $46.65 per share, with actual prices ranging from $46.40 to $47.05. These sales were executed under a pre-established Rule 10b5-1 trading plan adopted on September 11, 2025. After these transactions, Vashisht directly held 95,521 Genpact common shares.
Genpact LTD executive Piyush Mehta reported a routine tax-related share withholding. On 01/10/2026, 12,317 common shares were withheld at $48.24 per share to cover taxes due upon the vesting of restricted share units granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan, in a transaction exempt under Rule 16b-3.
After this transaction, Mehta directly beneficially owned 122,700 Genpact common shares. The filing also notes participation in the Genpact Employee Stock Purchase Plan, including 137 shares acquired since a prior Form 4, with a current total of 10,359 shares held under the ESPP.
Genpact Ltd’s Chief Financial Officer Michael Hal Weiner reported a routine tax-related share transaction. On January 10, 2026, 12,029 common shares were withheld at $48.24 per share to cover taxes due upon the vesting of restricted share units granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan, a transaction noted as exempt under Rule 16b-3. Following this withholding, Weiner beneficially owns 136,075 common shares directly. This total includes shares accumulated through the Genpact Employee Stock Purchase Plan, where he currently holds 1,436 shares, including 78 shares acquired since his prior Form 4 filed on November 17, 2025.
HEATHER D WHITE has filed a Form 144 notice to sell 10,740 shares of common stock of issuer G through Morgan Stanley Smith Barney LLC on or about 01/13/2026 on the NYSE. The planned sale has an aggregate market value of 500,964.08, compared with 172,414,423 shares of the same class reported as outstanding. The shares to be sold were acquired as restricted stock from the issuer on 01/10/2026.
Over the prior three months, the same seller reported three sales of common stock, totaling 45,703, 4,351, and 1,039 shares, for gross proceeds of 2,090,455.22, 199,014.74, and 45,731.59, respectively. By signing the notice, the seller represents that they are not aware of any material adverse, nonpublic information about the issuer’s current or prospective operations.
A holder of common shares of the issuer associated with symbol G has filed a Form 144 notice to sell 15,088 common shares through Morgan Stanley Smith Barney LLC on the NYSE. The planned sale has an indicated aggregate market value of $703,788.81, with 172,414,423 common shares reported as outstanding and an approximate sale date of 01/13/2026.
The shares to be sold were acquired as restricted stock from the issuer on 01/10/2026, with the same date noted for payment and the nature of payment listed as not applicable. Over the past three months, the same seller, Sameer Dewan, sold 26,531 common shares for gross proceeds of $1,185,999.38, which is disclosed alongside the new planned sale.